Pediatric pulmonary (lung and bronchial) services
The UC Davis Children’s Hospital maintains an outstanding pulmonary services unit that cares for infants, children, and adolescents who have lung and breathing disorders.
Our staff members offer expertise in diagnosis and treatment of:
- Cystic fibrosis, a recessive genetic disorder that affects the lungs as well as the pancreas, liver, and intestine; characterized by viscous secretions, its most serious symptom is difficulty breathing, the result of frequent lung infections
- Bronchopulmonary dysplasia, which develops most commonly in the first month of life in children who were born prematurely and is characterized by inflammation of the lungs
- Alpha-1 antitrypsin deficiency, an inherited disorder that interferes with the ability of the liver to manufacture a vital protein
- Chronic obstructive pulmonary disease, the name given to chronic bronchitis, asthma, and various other conditions that constrict passage of air in the respiratory system
- Pulmonary malformations, a group of rare developmental lung abnormalities affecting the airways, lung tissue, and blood vessels chronic lung diseases that can be caused by:
- Premature birth
- Genetic disorders such sleep-related respiratory disorders as apnea of prematurity, a condition in which premature infants stop breathing for 15 to 20 seconds during sleep
Pulmonology is the branch of medicine devoted to diagnosis and treatment of lung and breathing problems — bronchiopulmonary conditions.
The “bronchio-” prefix refers to the bronchial tubes, which are the air ducts leading into the lungs. The term “pulmonary” relates to functions and structures of the lungs.
Advanced diagnosis is available by means of our pediatric flexible bronchoscopy technology, a minimally invasive technique for directly visualizing and evaluating your child's airway anatomy using a flexible fiber-optic viewing tube.
Our services include a Pediatric Asthma Program and a Cystic Fibrosis Care Center that is accredited by the Cystic Fibrosis Foundation. We also conduct a comprehensive pediatric patient and family education program.
We sponsor a cystic fibrosis support group for patients and their families. During quarterly meetings held at the hospital, guest speakers discuss cystic fibrosis research, management and treatment.
Among our esteemed pediatricians and researchers are:
- Professor Kent E. Pinkerton, who also serves as professor in residence in the Department of Anatomy, Physiology and Cell Biology in the School of Veterinary Medicine, Director of the Center for Health and the Environment and Associate Director of the Western Center for Agricultural Health and Safety. His clinical and research interests focus on the effects of tobacco smoke, gases and particles on lung growth, lung development, immunoregulation, and neural control. He also studies the health impacts of engineered nanomaterials on the cardiopulmonary system.
- Assistant Professor Sanjay Jhawar, Board certified in Pediatrics, Pediatric Pulmonary Medicine and Pediatric Sleep medicine. His clinical interests in neonates and infants include chronic lung lisease related to prematurity, neonatal apnea, periodic breathing of prematurity and sudden infant death syndrome (SIDS). He is expert in obstructive sleep apnea of childhood, asthma, and cystic fibrosis. His other pulmonary interest include ciliary dyskinesia, pulmonary rheumatic disorders, pulmonary lymphatic disorders and care of tracheostomy and ventilator dependent children.